文献速递神经肿瘤

树突状细胞疫苗在新发弥漫性半球胶质瘤H3 G34突变同源小鼠模型中的疗效

Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant.
PubMed 文献 · J Neurooncol · 2026-04-02

研究利用RCAS/tv-A系统在C57BL/6新生小鼠神经祖细胞中表达H3G34R和PDGFβ并敲除p53,建立DHG同源小鼠模型。两周期肿瘤裂解物脉冲树突状细胞疫苗联合PD-1阻断可减轻肿瘤负荷并延长生存;治疗抵抗肿瘤中细胞外基质重塑相关基因表达升高。

要点

  • DC疫苗联合PD-1阻断在该模型中减轻肿瘤负荷并延长生存。
  • 治疗抵抗与肿瘤微环境细胞外基质重塑基因高表达相关。
  • 该模型可用于DHG免疫治疗机制与耐药研究。

核心结论

  • 自体树突状细胞负载肿瘤裂解物联合抗PD-1抗体可能对DHG有效。
  • 该模型中治疗失败与肿瘤微环境细胞外基质重塑相关基因表达增加有关。

研究设计与样本

  • 研究采用RCAS/tv-A系统在C57BL/6新生小鼠神经祖细胞中表达H3G34R和PDGFβ并敲除p53。
  • 获得三株表达少突胶质细胞和中间神经元谱系相关转录本的独立细胞系,颅内注射后产生致死性肿瘤。

主要发现

  • 两周期DC疫苗联合PD-1阻断减轻肿瘤负荷并提高生存。
  • 治疗抵抗肿瘤中细胞外基质重塑相关基因表达高于未治疗动物肿瘤。

临床怎么用

  • 提示DC疫苗联合PD-1阻断可作为DHG潜在免疫治疗策略进一步验证。
  • 治疗抵抗可能与细胞外基质重塑相关,需关注肿瘤微环境对免疫治疗的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The prognosis for pediatric high-grade gliomas associated with mutations in the H3-3A gene is very poor. To investigate whether tumor lysate-pulsed dendritic cells (DC) together with checkpoint blockade might be a potential treatment modality for diffuse hemispheric glioma H3 G34-mutant (DHG), we have developed a novel syngeneic mouse model. METHODS: We used the RCAS/tv-A system to target the expression of H3G34R and PDGFβ and knock out p53 in neural progenitors in C57BL/6 neonatal mice. Three independent cell lines were obtained that expressed transcripts associated with oligodendrocyte and interneuron lineages. Lethal tumor developed following intracranial injection. RESULTS: Two cycles of DC vaccination with PD-1 blockade decreased tumor burden and increased survival. In treatment resistant tumors we found higher expression of several genes involved in remodeling the extracellular matrix compared with tumors from untreated animals, suggesting a causal link to resistance to immunotherapy in this tumor model. CONCLUSION: Immunotherapy involving autologous dendritic cells pulsed with tumor lysate and combined with anti-PD-1 antibody might be an effective treatment for DHG. Treatment failure in our tumor model is associated with increased expression of genes implicated in remodeling extracellular matrix in the tumor microenvironment.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Owens GC, Contreras EM, Kienzler JC, et al. Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant. J Neurooncol. 2026. PMID: 41925941. doi:10.1007/s11060-026-05545-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。